Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 6,520,000 shares, an increase of 27.3% from the February 28th total of 5,120,000 shares. Approximately 7.2% of the company's shares are sold short. Based on an average trading volume of 1,880,000 shares, the days-to-cover ratio is presently 3.5 days.
Analyst Ratings Changes
Several research analysts recently issued reports on ACHC shares. Cantor Fitzgerald reissued a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada dropped their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Bank of America cut their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Mizuho lowered their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a research note on Tuesday, March 25th. Finally, KeyCorp cut their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Hold" and a consensus target price of $52.19.
Check Out Our Latest Analysis on Acadia Healthcare
Institutional Investors Weigh In On Acadia Healthcare
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Lindbrook Capital LLC grew its holdings in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. grew its stake in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC increased its position in Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares in the last quarter. Signaturefd LLC raised its stake in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after buying an additional 1,004 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its holdings in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after acquiring an additional 933 shares in the last quarter.
Acadia Healthcare Stock Down 3.6 %
Acadia Healthcare stock traded down $1.01 during trading hours on Friday, reaching $27.37. The stock had a trading volume of 1,613,368 shares, compared to its average volume of 1,418,642. Acadia Healthcare has a 52 week low of $26.54 and a 52 week high of $82.41. The company has a market cap of $2.54 billion, a price-to-earnings ratio of 8.97, a PEG ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business's 50 day moving average price is $35.62 and its 200-day moving average price is $43.59.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.